Page last updated: 2024-08-21

fluorobenzenes and Hepatitis C, Chronic

fluorobenzenes has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albrecht, J; Brown, K; Cates, C; Conrad, A; Elliott, L; George, J; Jhaveri, R; Kenedi, C; Kilaru, R; McHutchison, JG; Patel, K; Qiang, G; Tillmann, HL; Zekry, A	1

Other Studies

1 other study(ies) available for fluorobenzenes and Hepatitis C, Chronic

Article	Year
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C. Journal of viral hepatitis, 2011, Volume: 18, Issue:5 Topics: Cohort Studies; Female; Fluorobenzenes; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Prospective Studies; Pyrimidines; RNA, Viral; Rosuvastatin Calcium; Statistics as Topic; Sulfonamides	2011

Article

Year

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.

Journal of viral hepatitis, 2011, Volume: 18, Issue:5

Topics: Cohort Studies; Female; Fluorobenzenes; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Prospective Studies; Pyrimidines; RNA, Viral; Rosuvastatin Calcium; Statistics as Topic; Sulfonamides

2011